安非他酮
性功能障碍
萧条(经济学)
性功能
精神科
医学
心理学
抗抑郁药
内科学
戒烟
焦虑
宏观经济学
病理
经济
作者
Valeska Martinho Pereira,Óscar Arias-Carrión,Sérgio Machado,Antônio Egídio Nardi,Adriana Silva
出处
期刊:Cns & Neurological Disorders-drug Targets
[Bentham Science Publishers]
日期:2014-06-12
卷期号:13 (6): 1079-1088
被引量:33
标识
DOI:10.2174/1871527313666140612112630
摘要
Depression is the most prevalent psychiatric disorder (16.6%) and is frequently associated with impairments in several areas. Sexual dysfunction (SD) is a prevalent problem with rates ranging from 40-45% in adult women and 20- 30% in adult men. A relationship between depression and sexual dysfunction has been shown in the literature although the mechanisms of this association are not yet clear. Many antidepressants, especially selective serotonin reuptake inhibitors (SSRIs), list sexual dysfunction as a side effect. New drug alternatives with fewer side effects have been proposed, and bupropion is one of them. This study aims to review the literature on bupropion and its impact in sexual function on depressed subjects. Most of the studies have noted that bupropion is not only as effective as other antidepressants but has the advantage of a lower impact on sexual functioning. Some other studies have found that bupropion can even enhance sexual function in certain individuals. Bupropion is also effective, when combined with other antidepressants, in treating emergent sexual dysfunction. Bupropion may be an alternative treatment for depression that does not include the sexual side effects associated with most of the prescribed antidepressants available; however, additional research is required.
科研通智能强力驱动
Strongly Powered by AbleSci AI